Materias dentro de su búsqueda.
Mostrando 34,341 - 34,360 Resultados de 34,656 Para Buscar 'biguru~', tiempo de consulta: 4.45s Limitar resultados
  1. 34341
    “…Individual concentration-time profiles for patients receiving 2.5g IV q 8h are shown in the Figure. For patients receiving 2.5g IV q8h, CAZ and AVI median (IQR) AUCs were 525.6 hr*µg/ml (403.2, 762.0) and 83.7 (57.3, 129.5), respectively. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1298. Population Pharmacokinetics of Ceftazidime-avibactam among Critically-ill Patients with and without Receipt of Continuous Renal Replacement Therapy
  2. 34342
    “…On the other hand, the insulin-sensitising effect of long-term exercise in men may be explained by enhanced SkM and, to a lesser degree, also by enhanced ScWAT BCAA catabolism. [Figure: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00125-020-05296-0) contains peer-reviewed but unedited supplementary material, which is available to authorised users.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Branched-chain amino acid metabolism, insulin sensitivity and liver fat response to exercise training in sedentary dysglycaemic and normoglycaemic men
  3. 34343
    “…P values less than 0.05 were considered significant and designated as such in the Figures. LPS and cAMP regulators were from Sigma-Aldrich, MMP-9 standard and antibody and TNFα antibodies were from R&D Systems, and amyloid-β peptide was from rPeptide. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Inhibition of matrix metalloproteinase-9 secretion by dimethyl sulfoxide and cyclic adenosine monophosphate in human monocytes
  4. 34344
    “…J Head Trauma Rehabil. 1998;13(2):27-35. doi:10.1097/00001199-199804000-00005. TABLES/FIGURES:…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    DETERMINANTS OF IMMEDIATE AND DELAYED RECALL PERFORMANCE FOLLOWING PEDIATRIC CONCUSSION
  5. 34345
    “…The mechanisms by which anemia impacts outcomes in COVID-19 are likely to be multiple in nature and require further investigation. [Figure: see text] DISCLOSURES: Mascarenhas:Celgene, Prelude, Galecto, Promedior, Geron, Constellation, and Incyte: Consultancy; Incyte, Kartos, Roche, Promedior, Merck, Merus, Arog, CTI Biopharma, Janssen, and PharmaEssentia: Other: Research funding (institution).…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Mild Anemia As a Single Independent Predictor of Mortality in Patients with COVID-19
  6. 34346
    “…We are also examining the validation of a scoring system involving the platelet count among other parameters to use as a predictor for disease course and outcome. [Figure: see text] DISCLOSURES: No relevant conflicts of interest to declare.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Does Thrombocytopenia Truly Correlate with COVID-19 Severity?
  7. 34347
    “…This work demonstrates how an EHR is fundamental to the sustainability of vital cancer services for rural communities. [Figure: see text] DISCLOSURES: Hamad:Abbvie: Honoraria; Novartis: Honoraria.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A Shared Electronic Health Record in a Rural Setting Maintains Hematological Cancer Services Remotely during the COVID-19 Pandemic
  8. 34348
    “…This study provides proof of concept for prospective clinical trials for assessing the role of combination of antiplatelet therapy and therapeutic anticoagulation in high risk patients. [Figure: see text] DISCLOSURES: No relevant conflicts of interest to declare.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Evaluation of Antiplatelet and Anticoagulation Therapy in High-Risk COVID-19 Patients
  9. 34349
    “…Circular articular cartilage and subchondral bone graft models were created on all possible locations on the articular cartilage surface models of the donor patellae (Figure 1). The graft models were virtually placed on the surface of the defect model. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Factors Contributing to Graft Matching in a Patellar Osteochondral Allograft Selection Model (211)
  10. 34350
    “…The concordance indices for 6-year OS and DFS were 0.7 and 0.65 (Figure 1) respectively which represents a fairly accurate prediction by Sarculator. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Characteristics and Outcomes of Locally Recurrent Retroperitoneal Sarcoma After First Relapse in a Single Tertiary Asian Centre and Applicability of the Sarculator
  11. 34351
    “…In both study periods, virologic failures were detected in < 1% of PLWH with ≥ 1 viral load. Figure 1. Incidence rates for overall, in-person, and telehealth visits during the pre-COVID (open circle) and the COVID (filled circle) study periods [Image: see text] Incidence rates for viral load measurements during the pre-COVID (open circle) and the COVID (filled circle) study periods [Image: see text] Incidence rates for regimen discontinuation during the pre-COVID (open circle) and the COVID (filled circle) study periods [Image: see text] CONCLUSION: The COVID pandemic has led to an important reduction in the frequency and type of clinical follow-up visits and viral load monitoring among virally suppressed PLWH in the US. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    886. The Impact of the COVID-19 Pandemic on Clinical Follow-Up, Monitoring and Regimen Discontinuation for People Living with HIV in the US
  12. 34352
    “…We plan to expand our study to other centers to get more insight into health issues in older patients with hemophilia. [Figure: see text] DISCLOSURES: No relevant conflicts of interest to declare.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hemophilia in Patients 50 Years or Older: Quality of Life, Health Maintenance, Cancer Screening and COVID19
  13. 34353
    “…This observation provides proof-of-principle for the development of plant-based flavonoid therapies for inhibition of β-coronaviruses and supports the further evaluation of PGHG for therapeutic use in COVID19. [Figure: see text] DISCLOSURES: No relevant conflicts of interest to declare.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Inhibition of Sars-Cov-2 Viral Replication and In Vivo Thrombus Formation By a Novel Plant Flavonoid
  14. 34354
    “…Future research is needed to investigate approaches to provide protective IgG against SARS-CoV-2 in this at-risk population. [Figure: see text] DISCLOSURES: Mustafa:  Genentech: Speakers Bureau; GalaxoSmithKline: Speakers Bureau; CSL Behring: Speakers Bureau; Regeneron: Speakers Bureau; AstraZeneca: Speakers Bureau. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Evaluation of Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunizations in Patients with B-Cell Malignancies
  15. 34355
    “…In fact, median hospital stay for VOC is 4 [3-7] days (Bartolucci, 2016) whereas median homecare follow-up was 3 [1-6] days. [Figure: see text] DISCLOSURES: Bartolucci:  Hemanext: Consultancy; Jazz Pharma: Other: Lecture fees; AGIOS: Consultancy; F. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Drepadom - Establishment of Home Care Services and Hospitalizations for Sickle Cell Disease Patients As Standard Care Since the Covid-19 Pandemic
  16. 34356
    por Perini, Guilherme Fleury, Villela, Luis, Beltran, Brady E, Castro, Denisse, Otero, Victoria, Kalmus, Mariana, Fiad, Lorena, Peña, Camila, Idrobo, Henry, Candelaria, Myrna, Von Glasenapp, Alana, Perdomo, Ivan, Feres, Carolina, Prates, Maria Virginia, Paredes, Sally Rose, Perez-Jacobo, Fernando, Ramirez-Ibarguen, Ana Florencia, Gajardo, Claudia, Salinas, Macarena Alejandra Roa, Otañez, Melani, Valvert, Fabiola, Arcuri, Leonardo Javier, Montaño Figueroa, Efreen, Di Stefano, Marcos, Baena, Rosio, Choque, Juan Antonio, Abello, Virginia, Valladares, Ximena, Sanchez, Sofia, Nancy, Cristaldo, Zambrano, Daniela, Lasso, Juan Felipe, Noboa, Andrea, Rojas, Christine, Teixeira, Larissa LC, Ospina, Juan Alejandro, Torres Viera, Marialejandra Alejandra, Sotomayor, Eduardo, Martinez, Humberto, Castillo, Jorge J., Skarbnik, Alan, Malpica Castillo, Luis
    Publicado 2021
    “…There is an unmet need for improving survival in patients with hematologic malignancies and COVID-19 infection. [Figure: see text] DISCLOSURES: Perini:  Janssen: Honoraria, Speakers Bureau; Takeda: Honoraria, Speakers Bureau; Astra Zeneca: Honoraria, Speakers Bureau; MSD: Honoraria, Speakers Bureau. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Updated Analysis Confirms Sustained Poor Prognosis of COVID-19 in Patients with Lymphoma in Latin America: A Cohort of 160 Patients from Gell
  17. 34357
    “…There does not seem to be any significant correlation with disease severity and IFN-gamma levels. [Figure: see text] DISCLOSURES: No relevant conflicts of interest to declare.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Clinical and Immunological Assessment of Patients with Sars-Cov-2 Infections
  18. 34358
    “…These are largely shaped on the historical backdrop and level of trust people have in relevant authority figures (high confidence), although some have unwavering faith in their government and, by extension, the programme (moderate confidence). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Community views on mass drug administration for filariasis: a qualitative evidence synthesis
  19. 34359
    “…Exclusion criteria are listed in Figure 1, and included ages <15 years or > 55 years, bi-cruciate ligament injuries, and meniscal allograft transplant. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Paper 81: Quadriceps Tendon Autograft Yields Good Outcomes for Revision ACL Reconstruction after Failed Patellar Tendon Autograft
  20. 34360
    “…Mean postoperative opioid consumption was 5 pills (range 0 to 31 pills). 42% of patients consumed 0 opioid pills; 77% of patients consumed ≤ 5 opioid pills; 73% of patients discontinued opioid use after POD 2 (Figure 1). Patients reported a mean daily VAS value of 2.5 of 10; mean satisfaction with pain management was high at 4.16/5 on a Likert satisfaction score. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Poster 223: Evidence-Based Opioid Prescribing Guidelines Following Anterior Cruciate Ligament Reconstruction (ACLR)
Herramientas de búsqueda: RSS